Hypoxia but not cigarette smoke modulates VEGF secretion from human T cells

Growth Factors

Volumn 27, Issue 6, 2009, Pages 352-361

  Mikko, Mikael ^a   Wahlström, Jan ^a   Grunewald, Johan ^a   Sköld, C Magnus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cigarette smoke; COPD; Hypoxia; T cells; VEGF

Indexed keywords

CIGARETTE SMOKE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; RECOMBINANT VASCULOTROPIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOMODULATION; MALE; OXYGEN BLOOD LEVEL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; CELL HYPOXIA; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; T-LYMPHOCYTES; TOBACCO; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70450183818     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977190903210863     Document Type: Article

References (48)

1. Barcelo B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agusti AG. 2008. Phenotypic characterisation of T-lymphocytes in COPD: Abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 31(3):555-562.
2. Barleon B, Sozzani S, Zhou D,Weich HA, Mantovani A, Marme D. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87(8):3336-3343.
3. Ben-Shoshan J, Maysel-Auslender S, Mor A, Keren G, George J. 2008. Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol 38(9):2412-2418.
4. Berse B, Brown LF, Van deWater L, Dvorak HF, Senger DR. 1992. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3(2):211-220.
5. Boutten A, Bonay M, Laribe S, Leseche G, Castier Y, Lecon-Malas V, Fournier M, Durand G, Aubier M, Dehoux M, Crestani B. 2004. Decreased expression of interleukin 13 in human lung emphysema. Thorax 59(10):850-854.
6. Carcereny Costa E, Vinolas Segarra N, Gascon Vilaplana P. 2008. Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC). Clin Transl Oncol 10(4):198-203.
7. Carp H, Janoff A. 1978. Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. Am Rev Respir Dis 118(3):617-621.
8. Cheng SL, Wang HC, Yu CJ, Yang PC. 2008. Increased expression of placenta growth factor in COPD. Thorax 63(6):500-506.
9. Choi JM, Cho YC, Cho WJ, Kim TS, Kang BY. 2008. Hydroquinone, a major component in cigarette smoke, reduces IFN-gamma production in antigen-primed lymphocytes. Arch Pharm Res 31(3):337-341.
10. Collins PD, Connolly DT, Williams TJ. 1993. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol 109(1):195-199.
11. Daniel WW. 1995. Biostatistics: A foundation for analysis in the health sciences. New York: Wiley.
12. Elias JA, Kang MJ, Crothers K, Homer R, Lee CG. 2006. State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: Insights from transgenic mice. Proc Am Thorac Soc 3(6):494-498.
13. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M. 1995. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 55(18):4140-4145.
14. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. 1998. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 30-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273(46):30336-30343.
15. Glader P, von Wachenfeldt K, Lofdahl CG. 2006. Systemic CD4+T-cell activation is correlated with FEV1 in smokers. Respir Med 100(6):1088-1093.
16. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, Kheradmand F. 2004. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 1(1):e8.
17. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350(26): 2645-2653.
18. Hoshino M, Nakamura Y, Hamid QA. 2001. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 107(6):1034-1038.
19. Kanazawa H, Asai K, Hirata K, Yoshikawa J. 2003. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 114(5): 354-358.
20. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH. 2004. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114(8): 1098-1106.
21. Karhausen J, Haase VH, Colgan SP. 2005. Inflammatory hypoxia: Role of hypoxia-inducible factor. Cell Cycle 4(2):256-258.
22. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106(11):1311-1319.
23. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. 2001. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 163(3 Pt 1):737-744.
24. Kierszniewska-Stepien D, Pietras T, Gorski P, Stepien H. 2006. Serum vascular endothelial growth factor and its receptor level in patients with chronic obstructive pulmonary disease. Eur Cytokine Netw 17(1):75-79.
25. Kumar RK, Herbert C, Yang M, Koskinen AM, McKenzie AN, Foster PS. 2002. Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin Exp Allergy 32(7):1104-1111.
26. Lambert C, McCue J, Portas M, Ouyang Y, Li J, Rosano TG, Lazis A, Freed BM. 2005. Acrolein in cigarette smoke inhibits T-cell responses. J Allergy Clin Immunol 116(4):916-922.
27. Lee MH, Chung SW, Kang BY, Kim KM, Kim TS. 2002. Hydroquinone, a reactive metabolite of benzene, enhances interleukin-4 production in CD4+T cells and increases immunoglobulin E levels in antigen-primed mice. Immunology 106(4):496-502.
28. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, Kang MJ, Cohn L, Kim YK, McDonald DM, Elias JA. 2004. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10(10):1095-1103.
29. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408.
30. Maeno T, Houghton AM, Quintero PA, Grumelli S, Owen CA, Shapiro SD. 2007. CD8+T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol 178(12):8090-8096.
31. Matsuyama W, Kubota R, Hashiguchi T, Momi H, Kawabata M, Nakagawa M, Arimura K, Osame M. 2002. Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro. Immunology 106(1):96-101.
32. McManus TE, Marley AM, Baxter N, Christie SN, O'Neill HJ, Elborn JS, Coyle PV, Kidney JC. 2008. Respiratory viral infection in exacerbations of COPD. Respir Med 102(11): 1575-1580.
33. Michaud SE, Menard C, Guy LG, Gennaro G, Rivard A. 2003. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: Impairment of the HIF-1alpha/VEGF pathway. Faseb J 17(9):1150-1152.
34. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Kambouchner M, Valeyre D, Chapelon-Abric C, Debre P, Piette J-C, Gorochov G. 2006. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203(2):359-370.
35. Monacci WT, Merrill MJ, Oldfield EH. 1993. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264(4 Pt 1):C995-1002.
36. Mor F, Quintana FJ, Cohen IR. 2004. Angiogenesis-inflammation cross-talk: Vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 172(7):4618-4623.
37. Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. 2000. Suppression of human IL-1beta, IL-2, IFNgamma, and TNF-alpha production by cigarette smoke extracts. J Allergy Clin Immunol 106(2):280-287.
38. Pauwels RA, Rabe KF. 2004. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364(9434): 613-620.
39. Petreaca ML, Yao M,Ware C, Martins-Green MM. 2008. Vascular endothelial growth factor promotes macrophage apoptosis through stimulation of tumor necrosis factor superfamily member 14 (TNFSF14/LIGHT). Wound Repair Regen 16(5): 602-614.
40. RothenbergME. 2004. VEGFobstructs the lungs. Nat Med 10(10): 1041-1042.
41. Rovina N, Papapetropoulos A, Kollintza A, Michailidou M, Simoes DC, Roussos C, Gratziou C. 2007. Vascular endothelial growth factor: An angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease? Respir Res 8:53.
42. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. 1998. CD8+T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(3 Pt 1):822-826.
43. Thaikoottathil JV, Martin RJ, Zdunek J, Weinberger A, Rino JG, Chu HW. 2009. Cigarette smoke extract reduces VEGF in primary human airway epithelial cells. Eur Respir J 33(4): 835-843.
44. Tuder RM, Yun JH, Bhunia A, Fijalkowska I. 2007. Hypoxia and chronic lung disease. J Mol Med 85(12):1317-1324.
45. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman HA, Jr, Shapiro SD, Elias JA. 2000. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192(11):1587-1600.
46. Zheng T, Kang MJ, Crothers K, Zhu Z, LiuW, Lee CG, Rabach LA, Chapman HA, Homer RJ, Aldous D, De Sanctis GT, Underwood S, Graupe M, Flavell RA, Schmidt JA, Elias JA. 2005. Role of cathepsin S-dependent epithelial cell apoptosis in IFNgamma- induced alveolar remodeling and pulmonary emphysema. J Immunol 174(12):8106-8115.
47. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103(6):779-788.
48. Zittermann SI, Issekutz AC. 2006. Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation. J Leukoc Biol 80(2): 247-257.